SEARCH

SEARCH BY CITATION

References

  • 1
    Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968; 278: 352359.
  • 2
    Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973; 42: 441452.
  • 3
    Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. HEPATOLOGY 2008; 47: 20892111.
  • 4
    Dick AT. Studies on the accumulation and storage of copper in crossbred sheep. Austr J Agric Res 1954; 5: 511544.
  • 5
    Schouwink G. De hepato-cerebral degeneratie (met een onderozoek van de zinkstofwisseling), academisch proefschrift Amsterdam [in Dutch]. Amsterdam, Netherlands: University of Amsterdam; 1961.
  • 6
    Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 1985; 65: 238309.
  • 7
    Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007; 87: 10111046.
  • 8
    Hill CM, Brewer GJ, Prasad AS, Hydrick CR, Hartmann DE. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens. HEPATOLOGY 1987; 7: 522528.
  • 9
    Schilsky ML, Blank RR, Czaja MJ, Zern MA, Scheinberg IH, Stockert RJ, et al. Hepatocellular copper toxicity and its attenuation by zinc. J Clin Invest 1989; 84: 15621568.
  • 10
    Hoogenraad TU, Koevoet R, de Ruyter Korver EG. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979; 18: 205211.
  • 11
    Brewer GJ, Dick RD, Johnson VD, Fink JK, Kluin KJ, Daniels S. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years. J Lab Clin Med 2001; 7: 191198.
  • 12
    Brewer GJ, Johnson VD, Dick RD, Hedera P, Fink JK, Kluin KJ. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. HEPATOLOGY 2000; 31: 364370.
  • 13
    Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998; 132: 264278.
  • 14
    Linn FHH, Houwen RHJ, van Hatten J, van der Kleij S, van Erpecum KJ. Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients HEPATOLOGY 2009; 50: 14421452.
  • 15
    Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology 1991; 100: 762767.
  • 16
    Brewer GJ, Askari F, Lorincz MT, Carlson M, Schilsky M, Kluin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006; 63: 521527.
  • 17
    Arnon R, Calderon JF, Schilsky ML, Emre S, Shneider B. Wilson Disease in children: serum transaminases and urinary copper on triethylene tetramine dihydrochloride (Trientine) treatment. J Pediatr Gastroenterol Nutr 2007; 44: 596602.
  • 18
    Lipsky MA, Gollan JL. Treatment of Wilson's disease: in D-penicillamine we trust–what about zinc? HEPATOLOGY 1987; 7: 593595.
  • 19
    Ferenci P. Wilson's disease. Clin Gastroenterol Hepatol 2005; 3: 726733.